Literature DB >> 15290086

Lp(a) lipoprotein and lipids in patients with rheumatoid arthritis: serum levels and relationship to inflammation.

Dursun Dursunoğlu1, Harun Evrengül, Bülent Polat, Halil Tanriverdi, Veli Cobankara, Asuman Kaftan, Mustafa Kiliç.   

Abstract

OBJECTIVES: Changes in lipid profiles, Lp(a) lipoprotein, and acute phase reactants are associated with early atherosclerosis in rheumatoid arthritis (RA). The associations of Lp(a) levels with atherosclerotic disorders, diabetes, RA, and renal diseases suggest that Lp(a) might be involved in autoimmune reactions.
METHODS: Eighty-seven women with RA diagnosed according to American Rheumatism Association criteria (mean age 45.4+/-9.4 years) were recruited and 50 healthy women (mean age 44+/-10.7 years) included as a control group. Serum Lp(a), total cholesterol (TC), triglyceride (TG), LDL cholesterol (LDL-C), HDL cholesterol (HDL-C), and C-reactive protein levels were analyzed.
RESULTS: In the RA and C groups, serum Lp(a) levels were 39.2+/-20.6 mg/dl and 14.8+/-9.7 mg/dl, respectively (P<0.001). The TC levels were 188.4+/-41.8 mg/dl and 185.3+/-19.3 mg/dl (P>0.05), TG levels were 124.5+/-50.1 mg/dl and 94.6+/-24.9 mg/dl (P<0.01), HDL-C levels were 40.0+/-7.4 mg/dl and 52.8+/-4.8 mg/dl (P<0.01), and LDL-C levels were 123.4+/-24.6 mg/dl and 113.3+/-21.1 mg/dl (P>0.05). While serum CRP levels showed a positive correlation with Lp(a), they correlated negatively with HDL-C levels (r=0.83 and P<0.0001, r=-0.49 and P<0.0001, respectively). It was meaningful that Lp(a) correlated negatively with serum HDL-C level (r=-0.36, P<0.001).
CONCLUSIONS: It is suggested that higher serum Lp(a), lower HDL-C, higher TG level, and a high ratio of TC/HDL-C might show high risk of atherosclerosis. Inflammation in RA may cause changes in HDL-C and Lp(a) metabolisms.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15290086     DOI: 10.1007/s00296-004-0438-0

Source DB:  PubMed          Journal:  Rheumatol Int        ISSN: 0172-8172            Impact factor:   2.631


  32 in total

1.  Dyslipoproteinaemia in patients with active, chronic polyarthritis. A study on serum lipoproteins and triglyceride clearance (intravenous fat tolerance test).

Authors:  S Rössner; C Löfmark
Journal:  Atherosclerosis       Date:  1977-09       Impact factor: 5.162

2.  Lipid profiles in untreated patients with rheumatoid arthritis.

Authors:  Y B Park; S K Lee; W K Lee; C H Suh; C W Lee; C H Lee; C H Song; J Lee
Journal:  J Rheumatol       Date:  1999-08       Impact factor: 4.666

3.  Hemostatic factors and cardiovascular disease in active rheumatoid arthritis: an 8 year followup study.

Authors:  S Wållberg-Jonsson; M Cederfelt; S Rantapää Dahlqvist
Journal:  J Rheumatol       Date:  2000-01       Impact factor: 4.666

4.  New and classical risk factors--the Münster heart study (PROCAM).

Authors:  G Assmann; H Schulte; P Cullen
Journal:  Eur J Med Res       Date:  1997-06-16       Impact factor: 2.175

5.  Protein and carbohydrate composition of Lp(a)lipoprotein from human plasma.

Authors:  C Ehnholm; H Garoff; O Renkonen; K Simons
Journal:  Biochemistry       Date:  1972-08-15       Impact factor: 3.162

6.  Death rate and causes of death in patients with rheumatoid arthritis.

Authors:  H A Isomäki; O Mutru; K Koota
Journal:  Scand J Rheumatol       Date:  1975       Impact factor: 3.641

7.  Serum lipid pattern and apolipoproteins (A1 and B100) in active rheumatoid arthritis.

Authors:  M Magarò; L Altomonte; A Zoli; L Mirone; M P Ruffini
Journal:  Z Rheumatol       Date:  1991 May-Jun       Impact factor: 1.372

8.  Serum lipoprotein in active rheumatoid arthritis and other chronic inflammatory arthritides. I. Relativity to inflammatory activity.

Authors:  K L Svenson; H Lithell; R Hällgren; I Selinus; B Vessby
Journal:  Arch Intern Med       Date:  1987-11

Review 9.  Lipoprotein(a). A genetic risk factor for premature coronary heart disease.

Authors:  A M Scanu
Journal:  JAMA       Date:  1992-06-24       Impact factor: 56.272

10.  Lipoprotein (a), lipids, and lipoproteins in patients with rheumatoid arthritis.

Authors:  S Rantapää-Dahlqvist; S Wållberg-Jonsson; G Dahlén
Journal:  Ann Rheum Dis       Date:  1991-06       Impact factor: 19.103

View more
  44 in total

1.  Cardiovascular risk in patients with rheumatoid arthritis: assessment of several traditional risk parameters and a German risk score model.

Authors:  Janina Willers; Andreas Hahn
Journal:  Rheumatol Int       Date:  2011-11-16       Impact factor: 2.631

Review 2.  Changes in lipid levels with inflammation and therapy in RA: a maturing paradigm.

Authors:  Jamie Robertson; Mike J Peters; Iain B McInnes; Naveed Sattar
Journal:  Nat Rev Rheumatol       Date:  2013-06-18       Impact factor: 20.543

3.  Tumor necrosis factor receptor 2 M196R polymorphism in rheumatoid arthritis and osteoarthritis: relationship with sTNFR2 levels and clinical features.

Authors:  Edith Oregón-Romero; Mónica Vázquez-Del Mercado; Rosa Elena Navarro-Hernández; Norma Torres-Carrillo; Gloria Martínez-Bonilla; Iris Estrada-García; Héctor Rangel-Villalobos; José Francisco Muñoz-Valle
Journal:  Rheumatol Int       Date:  2006-07-27       Impact factor: 2.631

4.  Markers of adipose tissue macrophage content are negatively associated with serum HDL-C concentrations.

Authors:  Jianying He; Xiaoyuan Xu; Ann Francisco; Anthony Ferrante; Jonathan Krakoff
Journal:  Atherosclerosis       Date:  2010-12-23       Impact factor: 5.162

5.  Dynamics shared by two related proinflammatory conditions, rheumatoid arthritis and metabolic syndrome.

Authors:  Altan Onat
Journal:  Eur J Rheumatol       Date:  2014-03-01

6.  Lipoprotein(a) screening in young and middle-aged patients presenting with acute coronary syndrome.

Authors:  Ayman Jubran; Anna Zetser; Barak Zafrir
Journal:  Cardiol J       Date:  2018-09-20       Impact factor: 2.737

7.  Rheumatoid arthritis and atypical cardiovascular disease: inflammation changing the clinical presentation.

Authors:  Marco Iafolla
Journal:  Can Fam Physician       Date:  2013-05       Impact factor: 3.275

8.  Ethnicity may be a reason for lipid changes and high Lp(a) levels in rheumatoid arthritis.

Authors:  Mustafa Cesur; Zeynep Ozbalkan; Mehtap Akcil Temel; Yaşar Karaarslan
Journal:  Clin Rheumatol       Date:  2006-05-06       Impact factor: 2.980

Review 9.  Lipid paradox in rheumatoid arthritis: changes with rheumatoid arthritis therapies.

Authors:  Matxalen Amezaga Urruela; Maria E Suarez-Almazor
Journal:  Curr Rheumatol Rep       Date:  2012-10       Impact factor: 4.592

10.  Lack of association between glucocorticoid use and presence of the metabolic syndrome in patients with rheumatoid arthritis: a cross-sectional study.

Authors:  Tracey E Toms; Vasileios F Panoulas; Karen M J Douglas; Helen R Griffiths; George D Kitas
Journal:  Arthritis Res Ther       Date:  2008-12-17       Impact factor: 5.156

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.